Abstract
Summary
Generic injections are injections that have the same active ingredients, the same dosage, the same route of administration, the same dosage form, and the same indications as the original drug.
LPI (LP Information)' newest research report, the “Generic Injection Industry Forecast” looks at past sales and reviews total world Generic Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Generic Injection sales for 2023 through 2029. With Generic Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Generic Injection industry.
This Insight Report provides a comprehensive analysis of the global Generic Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Generic Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Generic Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Generic Injection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Generic Injection.
The global Generic Injection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Generic Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Generic Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Generic Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Generic Injection players cover Sanofi, Fresenius, Viatris, Pfizer, Teva Pharmaceuticals, Hikma Pharmaceuticals, Novartis, Amneal Pharmaceuticals and Gland Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Generic Injection market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Liquid Injection
Powder for Injection
Segmentation by application
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sanofi
Fresenius
Viatris
Pfizer
Teva Pharmaceuticals
Hikma Pharmaceuticals
Novartis
Amneal Pharmaceuticals
Gland Pharma
Allergan
Kelun Pharmaceutical
Jiangsu HRS
Qilu Pharmaceutical
Chiatai Tianqing
Hainan Poly Pharm
Yangzijiang Pharmaceutical Industry
Shijiazhuang Pharma Group
LPI (LP Information)' newest research report, the “Generic Injection Industry Forecast” looks at past sales and reviews total world Generic Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Generic Injection sales for 2023 through 2029. With Generic Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Generic Injection industry.
This Insight Report provides a comprehensive analysis of the global Generic Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Generic Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Generic Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Generic Injection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Generic Injection.
The global Generic Injection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Generic Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Generic Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Generic Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Generic Injection players cover Sanofi, Fresenius, Viatris, Pfizer, Teva Pharmaceuticals, Hikma Pharmaceuticals, Novartis, Amneal Pharmaceuticals and Gland Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Generic Injection market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Liquid Injection
Powder for Injection
Segmentation by application
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sanofi
Fresenius
Viatris
Pfizer
Teva Pharmaceuticals
Hikma Pharmaceuticals
Novartis
Amneal Pharmaceuticals
Gland Pharma
Allergan
Kelun Pharmaceutical
Jiangsu HRS
Qilu Pharmaceutical
Chiatai Tianqing
Hainan Poly Pharm
Yangzijiang Pharmaceutical Industry
Shijiazhuang Pharma Group
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Generic Injection Market Size 2018-2029
2.1.2 Generic Injection Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Generic Injection Segment by Type
2.2.1 Liquid Injection
2.2.2 Powder for Injection
2.3 Generic Injection Market Size by Type
2.3.1 Generic Injection Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Generic Injection Market Size Market Share by Type (2018-2023)
2.4 Generic Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Generic Injection Market Size by Application
2.5.1 Generic Injection Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Generic Injection Market Size Market Share by Application (2018-2023)
3 Generic Injection Market Size by Player
3.1 Generic Injection Market Size Market Share by Players
3.1.1 Global Generic Injection Revenue by Players (2018-2023)
3.1.2 Global Generic Injection Revenue Market Share by Players (2018-2023)
3.2 Global Generic Injection Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Generic Injection by Regions
4.1 Generic Injection Market Size by Regions (2018-2023)
4.2 Americas Generic Injection Market Size Growth (2018-2023)
4.3 APAC Generic Injection Market Size Growth (2018-2023)
4.4 Europe Generic Injection Market Size Growth (2018-2023)
4.5 Middle East & Africa Generic Injection Market Size Growth (2018-2023)
5 Americas
5.1 Americas Generic Injection Market Size by Country (2018-2023)
5.2 Americas Generic Injection Market Size by Type (2018-2023)
5.3 Americas Generic Injection Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Generic Injection Market Size by Region (2018-2023)
6.2 APAC Generic Injection Market Size by Type (2018-2023)
6.3 APAC Generic Injection Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Generic Injection by Country (2018-2023)
7.2 Europe Generic Injection Market Size by Type (2018-2023)
7.3 Europe Generic Injection Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Generic Injection by Region (2018-2023)
8.2 Middle East & Africa Generic Injection Market Size by Type (2018-2023)
8.3 Middle East & Africa Generic Injection Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Generic Injection Market Forecast
10.1 Global Generic Injection Forecast by Regions (2024-2029)
10.1.1 Global Generic Injection Forecast by Regions (2024-2029)
10.1.2 Americas Generic Injection Forecast
10.1.3 APAC Generic Injection Forecast
10.1.4 Europe Generic Injection Forecast
10.1.5 Middle East & Africa Generic Injection Forecast
10.2 Americas Generic Injection Forecast by Country (2024-2029)
10.2.1 United States Generic Injection Market Forecast
10.2.2 Canada Generic Injection Market Forecast
10.2.3 Mexico Generic Injection Market Forecast
10.2.4 Brazil Generic Injection Market Forecast
10.3 APAC Generic Injection Forecast by Region (2024-2029)
10.3.1 China Generic Injection Market Forecast
10.3.2 Japan Generic Injection Market Forecast
10.3.3 Korea Generic Injection Market Forecast
10.3.4 Southeast Asia Generic Injection Market Forecast
10.3.5 India Generic Injection Market Forecast
10.3.6 Australia Generic Injection Market Forecast
10.4 Europe Generic Injection Forecast by Country (2024-2029)
10.4.1 Germany Generic Injection Market Forecast
10.4.2 France Generic Injection Market Forecast
10.4.3 UK Generic Injection Market Forecast
10.4.4 Italy Generic Injection Market Forecast
10.4.5 Russia Generic Injection Market Forecast
10.5 Middle East & Africa Generic Injection Forecast by Region (2024-2029)
10.5.1 Egypt Generic Injection Market Forecast
10.5.2 South Africa Generic Injection Market Forecast
10.5.3 Israel Generic Injection Market Forecast
10.5.4 Turkey Generic Injection Market Forecast
10.5.5 GCC Countries Generic Injection Market Forecast
10.6 Global Generic Injection Forecast by Type (2024-2029)
10.7 Global Generic Injection Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Generic Injection Product Offered
11.1.3 Sanofi Generic Injection Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Fresenius
11.2.1 Fresenius Company Information
11.2.2 Fresenius Generic Injection Product Offered
11.2.3 Fresenius Generic Injection Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Fresenius Main Business Overview
11.2.5 Fresenius Latest Developments
11.3 Viatris
11.3.1 Viatris Company Information
11.3.2 Viatris Generic Injection Product Offered
11.3.3 Viatris Generic Injection Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Viatris Main Business Overview
11.3.5 Viatris Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Generic Injection Product Offered
11.4.3 Pfizer Generic Injection Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Information
11.5.2 Teva Pharmaceuticals Generic Injection Product Offered
11.5.3 Teva Pharmaceuticals Generic Injection Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Teva Pharmaceuticals Main Business Overview
11.5.5 Teva Pharmaceuticals Latest Developments
11.6 Hikma Pharmaceuticals
11.6.1 Hikma Pharmaceuticals Company Information
11.6.2 Hikma Pharmaceuticals Generic Injection Product Offered
11.6.3 Hikma Pharmaceuticals Generic Injection Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Hikma Pharmaceuticals Main Business Overview
11.6.5 Hikma Pharmaceuticals Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Generic Injection Product Offered
11.7.3 Novartis Generic Injection Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 Amneal Pharmaceuticals
11.8.1 Amneal Pharmaceuticals Company Information
11.8.2 Amneal Pharmaceuticals Generic Injection Product Offered
11.8.3 Amneal Pharmaceuticals Generic Injection Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Amneal Pharmaceuticals Main Business Overview
11.8.5 Amneal Pharmaceuticals Latest Developments
11.9 Gland Pharma
11.9.1 Gland Pharma Company Information
11.9.2 Gland Pharma Generic Injection Product Offered
11.9.3 Gland Pharma Generic Injection Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Gland Pharma Main Business Overview
11.9.5 Gland Pharma Latest Developments
11.10 Allergan
11.10.1 Allergan Company Information
11.10.2 Allergan Generic Injection Product Offered
11.10.3 Allergan Generic Injection Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Allergan Main Business Overview
11.10.5 Allergan Latest Developments
11.11 Kelun Pharmaceutical
11.11.1 Kelun Pharmaceutical Company Information
11.11.2 Kelun Pharmaceutical Generic Injection Product Offered
11.11.3 Kelun Pharmaceutical Generic Injection Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Kelun Pharmaceutical Main Business Overview
11.11.5 Kelun Pharmaceutical Latest Developments
11.12 Jiangsu HRS
11.12.1 Jiangsu HRS Company Information
11.12.2 Jiangsu HRS Generic Injection Product Offered
11.12.3 Jiangsu HRS Generic Injection Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Jiangsu HRS Main Business Overview
11.12.5 Jiangsu HRS Latest Developments
11.13 Qilu Pharmaceutical
11.13.1 Qilu Pharmaceutical Company Information
11.13.2 Qilu Pharmaceutical Generic Injection Product Offered
11.13.3 Qilu Pharmaceutical Generic Injection Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Qilu Pharmaceutical Main Business Overview
11.13.5 Qilu Pharmaceutical Latest Developments
11.14 Chiatai Tianqing
11.14.1 Chiatai Tianqing Company Information
11.14.2 Chiatai Tianqing Generic Injection Product Offered
11.14.3 Chiatai Tianqing Generic Injection Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Chiatai Tianqing Main Business Overview
11.14.5 Chiatai Tianqing Latest Developments
11.15 Hainan Poly Pharm
11.15.1 Hainan Poly Pharm Company Information
11.15.2 Hainan Poly Pharm Generic Injection Product Offered
11.15.3 Hainan Poly Pharm Generic Injection Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Hainan Poly Pharm Main Business Overview
11.15.5 Hainan Poly Pharm Latest Developments
11.16 Yangzijiang Pharmaceutical Industry
11.16.1 Yangzijiang Pharmaceutical Industry Company Information
11.16.2 Yangzijiang Pharmaceutical Industry Generic Injection Product Offered
11.16.3 Yangzijiang Pharmaceutical Industry Generic Injection Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Yangzijiang Pharmaceutical Industry Main Business Overview
11.16.5 Yangzijiang Pharmaceutical Industry Latest Developments
11.17 Shijiazhuang Pharma Group
11.17.1 Shijiazhuang Pharma Group Company Information
11.17.2 Shijiazhuang Pharma Group Generic Injection Product Offered
11.17.3 Shijiazhuang Pharma Group Generic Injection Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Shijiazhuang Pharma Group Main Business Overview
11.17.5 Shijiazhuang Pharma Group Latest Developments
12 Research Findings and Conclusion